Evaluation of ivermectin distribution in Benin, Côte d'Ivoire, Ghana and Togo : estimation of coverage of treatment and operational aspects of the distribution system.
Ivermectin distribution by the Onchocerciasis Control Programme (OCP) was assessed in Benin, Côte d'Ivoire, Ghana and Togo, in terms of the proportion of villages which had been treated and the proportion of villagers in each village treated in the last round who had actually received treatment.
These proportions were evaluated both for treatment in the last round of ivermectin distribution and for treatment since the beginning of the drug's distribution in each country.
During the last treatment round, 97 (74.6%) of the 130 selected villages investigated in the four countries had received ivermectin treatment, and 67.2% of the members of these 97 treated communities had taken ivermectin.
In general, higher percentages of the members of treated villages in Côte d'Ivoire and Ghana had been treated [with mean (S.D.) percentage values of 72.0 (5.2) and 71.6 (4.6), respectively] than in those of Togo [61.8 (5.6) ] or Benin [64.2 (4.6) ]. Overall, 893 (26.1%) of those interviewed had never received treatment since the beginning of ivermectin distribution but 29.4% had received all the annual treatments.
The main reason for non-treatment during the last treatment round was absence from village (54.5% of those not treated), followed by non-eligibility (i.e. pregnant women and young children ; 12.2%) ; refusal to take treatment (2.6%), and shortage of drugs (1.9%). (...)
Mots-clés Pascal : Campagne de masse, Evaluation, Distribution, Ivermectine, Traitement, Chimiothérapie, Onchocercose, Filariose, Nématodose, Helminthiase, Parasitose, Infection, Afrique Ouest, Afrique, Homme, Effet secondaire, Peau pathologie, Oeil pathologie, Antiparasitaire, Anthelminthique
Mots-clés Pascal anglais : Mass campaign, Evaluation, Distribution, Ivermectin, Treatment, Chemotherapy, Onchocerciasis, Filariosis, Nematode disease, Helminthiasis, Parasitosis, Infection, West Africa, Africa, Human, Secondary effect, Skin disease, Eye disease, Parasiticid, Anthelmintic
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 97-0302335
Code Inist : 002B05E03B4C. Création : 15/07/1997.